Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 13, 16:00
2822.85
-82.65 (-2.84%)
VOLUME 45,474
LIVE
NSE
Dec 13, 15:59
2821.50
-84.15 (-2.9%)
VOLUME 1,368,418
News on Dr Reddys Laboratories
Select Year: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Dr Reddy's launches chronic iron overload treatment tablets in US

1.45 pm | 06 Dec 2019 |  Source: PTI

The company has launched its product, a generic version of Novartis Pharma AG's Exjade tablets for oral suspension, after getting the nod from the...

Dr Reddy's launches cancer treatment injection in US

1.35 pm | 04 Dec 2019 |  Source: PTI

The company has launched Bortezomib for Injection 3.5 mg/vial, approved by the United States Food and Drug Administration (USFDA) via a new drug appli...

Chinese strategy: Dr Reddy's outsources part manufacturing to local parties

3.05 pm | 21 Nov 2019 |  Source: PTI

The company which won the tender to market Olanzapine drug in China, is expected to launch it beginning next year, the official said....

Frequent FDA inspections slow down Indian pharma exports, says GV Prasad

5.23 pm | 18 Nov 2019 |  Source: PTI

According to him, China is a major source of active pharmaceutical ingredients (API) and chemical intermediaries for the global pharmaceutical industr...

1
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.